Although ATF6B (activating transcription factor 6 beta) and ITGA1 (integrin subunit alpha 1) were not successfully validated, we cannot rule out the possibility of false negatives due to differences between the transcriptome datasets used for validation, and they are potentially interesting candidates for COPD. This evidence concerns the gene ATF6B and chronic obstructive pulmonary disease.